Hope Bancorp (HOPE) Q1 2026 Earnings Transcript

Hope Bancorp reported first-quarter net income of $30 million, up 40% year over year, with net interest income up 23% to $124 million and net interest margin steady at 2.90%. Asset quality improved as criticized loans fell 28% year over year to $325 million, while the bank repurchased $7 million of stock and maintained its $0.14 quarterly dividend. Management also guided to over 20% loan growth and 15%-20% revenue growth in 2026, aided by the pending SMBC Manubank deal expected to close later this year.

Analysis

HOPE is transitioning from a balance-sheet repair story to a funded-growth story, and the important second-order effect is not the headline loan growth but the mix shift. The acquisition adds low-CD deposits into a franchise that has been paying down expensive funding, which should keep deposit beta falling even if the Fed stays on hold; that creates a cleaner path to margin expansion in the back half of the year and a sharper jump in 2027 when acquisition cost saves hit. The market is likely underappreciating how much of the current earnings improvement is self-help rather than rate cycle beta, which makes the setup more durable than a pure NIM trade.

The real constraint is not earnings quality but concentration optics. Pro forma CRE leverage around the low-300s remains elevated, so the company is intentionally throttling CRE growth ahead of close; that likely suppresses near-term top-line excitement but reduces the probability of a bad headline or regulatory friction later. In other words, slower CRE now is a call option on a cleaner Manubank approval and a less punitive capital discussion over the next 6-12 months.

Credit looks manageable, but the elevated charge-offs matter because they tell you the cleanup is still in progress. The key risk is that a few more quarters of realized losses could force the market to pay less for the improving NIM because investors will anchor on loan loss normalization rather than pre-provision growth. If criticized assets keep falling and charge-offs normalize back toward prior-quarter levels over the next two quarters, the stock can re-rate; if not, the move becomes a lower-quality earnings story with less multiple support.

Consensus may be too focused on the acquisition headline and not enough on funding mix. The transaction is effectively a deposit-franchise enhancement with embedded cost of funds leverage, which is more valuable in a flat-rate environment than a generic loan acquisition. That makes the equity attractive on a 12-18 month basis, but only if management avoids overextending CRE to defend short-term growth.

Key Decisions for Investors

• Go long HOPE on a 3-6 month horizon on any post-earnings weakness below current levels; the setup is asymmetric because deposit-cost compression can keep driving EPS even without Fed cuts, while acquisition accretion is a 2027 catalyst.
• Prefer a pair trade: long HOPE / short a higher-valuation regional bank with weaker deposit mix and no M&A-funded growth catalyst; HOPE should outperform if rates stay flat and funding costs keep drifting lower.
• Use a call spread on HOPE for the Manubank approval window (6-9 months): upside comes from a cleaner funding profile and 2027 accretion, while downside is capped by moderate operating momentum and buybacks.
• If you already own HOPE, hedge the near-term credit overhang with a partial trim ahead of the next two quarters; re-add if charge-offs revert and criticized assets continue to improve, since that is the trigger for multiple expansion.
• Avoid chasing the stock solely on the acquisition announcement; the better entry is after regulatory timing risk is better quantified, because the market may fade the name if CRE concentration headlines flare before close.